Direct sampling of a clinically visible vesiculobullous lesion from female genital lesion only.
Special Collection Procedure
Aseptically remove sterile swab from package. Collect specimen by vigorously swabbing the clinically visible vesiculobullous lesion. Aseptically remove cap from vial. Place swab in transport medium and break off swab against rim of the tube. Replace cap. Label the vial with patient's name.
Complete the Incyte Diagnostics requisition with the patient's demographics and relevant clinical history. Label specimen container with the patient's full first and last name, second unique identifier, and specimen source/site.
Specimen is stable at room temperature for up to 21 days
Unacceptable Specimen Conditions
Unlabeled specimens. Specimens in incorrect fixative (such as formalin).
The ARIES® HSV 1&2 Assay is a real-time polymerase chain reaction (PCR) based qualitative in vitro diagnostic test for the direct detection and differentiation of Herpes Simplex Virus 1 and 2 (HSV 1 and HSV 2) DNA in cutaneous or mucocutaneous lesion specimens from symptomatic patients. The test is indicated for use as an aid in diagnosis of HSV infection in symptomatic patients.
1–2 business days from receipt
21 days from submission
Herpes testing is intended for use on a visible lesion. Herpes collection must be performed with a separate dedicated Incyte Swab. Other cutaneous or mucocutaneous lesions from other sites must be collected using UTM (Universal Viral Transport Medium). For collection instructions see: Herpes Simplex Virus by UTM